Adverts

Open Access Articles- Top Results for Indeloxazine

Indeloxazine

</th></tr>
Indeloxazine
File:Indeloxazine.svg
Systematic (IUPAC) name
2-(3H-Inden-4-yloxymethyl)morpholine
Clinical data
  • Withdrawn
Identifiers
60929-23-9 7pxY
None
PubChem CID 3704
ChemSpider 3576 7pxY
UNII 834M09R1KM 7pxY
KEGG D08077 7pxY
Chemical data
Formula C14H17NO2
231.290 g/mol
 14pxY (what is this?)  (verify)

Indeloxazine (Elen, Noin) was a drug that was marketed in Japan and South Korea by Yamanouchi Pharmaceutical Co., Ltd for the treatment of psychiatric symptoms associated with cerebrovascular diseases, namely depression resulting from stroke, emotional disturbance, and reduced volition.[1][2] It was marketed from 1988[2] to 1998, when it was removed from the market for lack of effectiveness.[3]


References

  1. Index nominum, international drug ... - Google Books. 2000. ISBN 978-3-88763-075-1. 
  2. 2.0 2.1 r Ganellin, C; j Triggle, D; MacDonald, F. (1997). Dictionary of pharmacological agents - Google Books. ISBN 978-0-412-46630-4. 
  3. Hayashi, K; Hashimoto, K; Yanagi, M; Umeda, T; Hama, R (8 August 1998). "Drug approval in Japan questioned.". Lancet 352 (9126): 491. PMID 9708787. doi:10.1016/s0140-6736(05)79232-1. 



Lua error in package.lua at line 80: module 'Module:Buffer' not found.